Evidence map›Paper›PMID 42171570›Full record

ArticleJACC. Case reports2026

Late Embolization of a Patent Foramen Ovale Occluder Successfully Retrieved Percutaneously.

Fadhel Nabil Hamidani, Horst Sievert, Mohammed Musallam, Lars Platschek, Stephan Hohmann, Blerim Berisha

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fadhel Nabil HamidaniDepartment of Cardiology, St. Bernward Krankenhaus, Hildesheim, Germany. Electronic address: fadhelnabilhamidani@gmail.com.
Horst SievertCardioVascular Center, Frankfurt, Germany.
Mohammed MusallamDepartment of Cardiology, St. Bernward Krankenhaus, Hildesheim, Germany.
Lars PlatschekDepartment of Cardiology, St. Bernward Krankenhaus, Hildesheim, Germany.
Stephan HohmannDepartment of Cardiology, St. Bernward Krankenhaus, Hildesheim, Germany.
Blerim BerishaDepartment of Cardiology, Kreisklinik Roth, Roth, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPercutaneous patent foramen ovale (PFO) closure is an established therapy for secondary prevention of cryptogenic stroke. Device embolization is a rare but potentially serious complication, usually occurring early after implantation. CASE SUMMARY: A 68-year-old woman underwent PFO closure after ischemic stroke. At 3-month follow-up, the device was not visualized on transthoracic or transesophageal echocardiography. Computed tomography angiography revealed embolization to the distal abdominal aorta. The device was successfully retrieved using a percutaneous snare technique; retrieval was complicated by an infrarenal aortic dissection that was managed conservatively. Three weeks later, the patient experienced recurrent ischemic stroke and underwent repeat PFO closure with a larger device, without further complications. DISCUSSION: Percutaneous retrieval is a feasible first-line strategy in hemodynamically stable patients. Careful anatomical assessment and appropriate device sizing are essential to reduce the risk of embolization. TAKE-HOME MESSAGES: This case highlights the importance of appropriate PFO occluder sizing in patients with PFO and atrial septum aneurysm to minimize the risk of device embolization. Although retrieval of a PFO occluder embolized into the aorta carries a risk of aortic wall injury, a percutaneous approach should be considered the first-line management strategy.

Indexed as

aortic dissectionembolized occluderpatent foramen ovalepercutaneous retrieval

Identifiers

PMID42171570
PMCPMC13326180

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.